Dentition

DEXIS Drives Dental Imaging Innovation with Introduction of AI-Powered Implant Ecosystem

Retrieved on: 
Monday, February 12, 2024

The ecosystem is designed to empower clinicians to manage each step of an implant case, from diagnosis to delivery, with one integrated tool set.

Key Points: 
  • The ecosystem is designed to empower clinicians to manage each step of an implant case, from diagnosis to delivery, with one integrated tool set.
  • The DEXIS digital ecosystem is no exception and continues to uphold that same tradition of excellence.
  • With this prosthetic-driven implant system, you'll gain access to an open imaging platform, complete with diagnostics and treatment planning software, driven by Assisted Intelligence and tailored specifically for implant workflows.
  • Recognizing the daily challenges of managing data, processes and expectations, the DEXIS digital ecosystem takes pride in its simplicity.

Align Technology Announces New iTero Lumina™ Intraoral Scanner Featuring a 3X Wider Field of Capture1 in a 50% Smaller Wand2 That Delivers Faster Scanning, Higher Accuracy3, and Superior Visualization4 for Greater Practice Efficiency

Retrieved on: 
Wednesday, January 31, 2024

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240131690746/en/
    iTero Lumina™ intraoral scanner wand.
  • “Today we’re excited to introduce the next generation of iTero scanning technology that pushes the boundaries of what the industry has come to expect from a scanner,” said Karim Boussebaa, Align Technology executive vice president and managing director for the iTero scanner and services business.
  • I can confidently show my patients that I have the best, the most accurate, the fastest and importantly the most effective integration of digital workflow when treating them with Invisalign.
  • For information about iTero Lumina intraoral scanner availability, please contact your Align Technology representative.

The Inner Circle Acknowledges, Bruce S. Fine Top Pinnacle Professional for his contributions to the field of Comprehensive Family Dental Care

Retrieved on: 
Monday, January 15, 2024

WAYNE, N.J., Jan. 15, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Bruce S. Fine is acknowledged as a Top Pinnacle Professional for his contributions to the field of Comprehensive Family Dental Care.

Key Points: 
  • WAYNE, N.J., Jan. 15, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Bruce S. Fine is acknowledged as a Top Pinnacle Professional for his contributions to the field of Comprehensive Family Dental Care.
  • Additionally, he has received a Mastery Award (AADSM) from the American Academy of Dental Sleep Medicine.
  • There is now a dramatic change in dental implants that can solve these problems more comfortably, and significantly less expensively.
  • Upon graduating from Dental School, he was hired by his Professor and taught at Georgetown University Dental School.

Align Technology Receives US FDA 510(k) Clearance for the Invisalign® Palatal Expander System to Address Skeletal and Dental Expansion in Growing Patients, Including Teenage Patients Which Represent the Majority of Orthodontic Case Starts Globally

Retrieved on: 
Monday, December 18, 2023

The FDA 510(k) clearance is for broad patient applicability, including growing children, teens, and adults (with surgery or other techniques).

Key Points: 
  • The FDA 510(k) clearance is for broad patient applicability, including growing children, teens, and adults (with surgery or other techniques).
  • Invisalign Palatal Expanders are intended for use in rapid expansion and subsequent holding of skeletal and/or dental narrow maxilla (upper jaw) with primary, mixed, or permanent dentition during treatment of patients.
  • **Based on data from a multi-site US IDE (Investigational Device Exemption) clinical study (n=29 subjects, ages 7-10 years) of expansion treatment with Invisalign® Palatal Expanders.
  • Data on file at Align Technology, Inc. as of October 30, 2023
    ***Data on File at Align Technology, Inc. as of June 2021.

Health Canada Issues Updated Medical Device License to Align Technology For the Invisalign® Palatal Expander System to Address Skeletal and Dental Expansion

Retrieved on: 
Wednesday, December 13, 2023

Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that Health Canada issued an updated medical device license to Align for its Invisalign® Palatal Expander System*.

Key Points: 
  • Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that Health Canada issued an updated medical device license to Align for its Invisalign® Palatal Expander System*.
  • The Invisalign Palatal Expander System is available on a limited basis in Canada.
  • (Photo: Business Wire)
    Previously introduced at the Align Technology Investor Day in September 2023, the Invisalign Palatal Expander System is a modern and innovative direct 3D printed device based on proprietary and patented technology.
  • Data on file at Align Technology, Inc. as of October 30, 2023
    ***Data on File at Align Technology, as of June 2021.

The Inner Circle Acknowledges, Bruce S. Fine as a Top Pinnacle Professional for his contributions to the field of Comprehensive Family Dental Care

Retrieved on: 
Wednesday, November 29, 2023

WAYNE, N.J., Nov. 29, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Bruce S. Fine is acknowledged as a Top Pinnacle Professional for his contributions to the field of Comprehensive Family Dental Care.

Key Points: 
  • WAYNE, N.J., Nov. 29, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Bruce S. Fine is acknowledged as a Top Pinnacle Professional for his contributions to the field of Comprehensive Family Dental Care.
  • Additionally, he has received a Mastery Award (AADSM) from the American Academy of Dental Sleep Medicine.
  • There is now a dramatic change in dental implants that can solve these problems more comfortably, and significantly less expensively.
  • Upon graduating from Dental School, he was hired by his Professor and taught at Georgetown University Dental School.

Align Technology Introduces the Invisalign® Palatal Expander System to Address Skeletal Expansion in Growing Patients, Including Teenage Patients Which Represent the Majority of Orthodontic Case Starts Globally

Retrieved on: 
Wednesday, September 6, 2023

Invisalign Palatal Expanders are intended for use in rapid expansion and subsequent holding of skeletal and/or dental narrow maxilla (upper jaw) with primary, mixed, or permanent dentition during treatment of growing patients.

Key Points: 
  • Invisalign Palatal Expanders are intended for use in rapid expansion and subsequent holding of skeletal and/or dental narrow maxilla (upper jaw) with primary, mixed, or permanent dentition during treatment of growing patients.
  • View the full release here: https://www.businesswire.com/news/home/20230906445005/en/
    Dr. Sandra Tai’s patient independently inserting Invisalign® Palatal Expander.
  • A palatal expansion treatment plan and device design are then developed using Align’s proprietary AI-driven orthodontic software.
  • Based on data from a multi-site US Early Feasibility Investigational Device Exemption (IDE) clinical study (n=29 subjects, ages 7-10 years) of expansion treatment with Invisalign® Palatal Expanders.

Berkshire Biomedical Announces Two Poster Presentations at the CPDD 85th Annual Scientific Meeting

Retrieved on: 
Tuesday, June 20, 2023

DALLAS, June 20, 2023 /PRNewswire/ -- Berkshire Biomedical Corporation ("Berkshire" or the "Company"), focused on developing its proprietary drug dispensing technology to enhance patient wellness, announced today that two posters on the Company's Computerized Oral Prescription Administration System (COPA) were presented yesterday at The College on Problems of Drug Development (CPDD) 85th Annual Scientific Meeting, currently being held through Wednesday, June 21, 2023 in Denver, CO. The COPA is a novel, oral liquid dispensing system specifically designed to deliver accurate and precise doses of controlled and non-controlled prescription medications to only an Authenticated Intended User (AIU™), upon confirmation of dual biometric identifications, (fingerprint and dentition), with the goal of enhancing patient wellness and providing remote monitoring.

Key Points: 
  • "The opportunity to present two posters at such an important scientific meeting speaks volumes about the potential technological strength and versatility of our proprietary, cloud-based, healthcare-enabled COPA device," stated John Timberlake, Chief Executive Officer of Berkshire.
  • "COPA may significantly increase the safety and effectiveness of take-home methadone medication administration for opioid use disorder, thus potentially reducing patient burden, improving clinic operational efficiencies, and enhancing patient outcomes.
  • Details of the poster presentations are below:
    Poster Author & Poster Number: John Timberlake, et al (Poster # 3007513)
    Over 500,000 people in the US receive oral liquid methadone to treat opioid use disorder, which, by law, currently is only accessible from federally certified opioid treatment programs.
  • This device may reduce barriers to treatment for methadone patients, improve clinic efficiency, and expand the flexibility of settings for methadone administration.

RevBio Receives a Strategic Investment from Pacific Dental Services to Support Ongoing Clinical Trials in Implant Dentistry

Retrieved on: 
Tuesday, February 14, 2023

RevBio, Inc. announced that it has received a strategic investment from Pacific Dental Services® (PDS) to support the clinical development of its bone adhesive biomaterial for implant dentistry.

Key Points: 
  • RevBio, Inc. announced that it has received a strategic investment from Pacific Dental Services® (PDS) to support the clinical development of its bone adhesive biomaterial for implant dentistry.
  • Based in Irvine, California, PDS was founded in 1994 and is one of the leading dental support organizations in the U.S. with over 900 dental practices in 25 states.
  • (Photo: Business Wire)
    RevBio is currently in the clinical stage of development for its regenerative adhesive biomaterial for stabilizing dental implants .
  • “We believe the TETRANITE technology holds great promise in improving the clinical experience for patients in need of implant dentistry.”

Bio-LCB: Light Cured Base and Liner - Is Now Available

Retrieved on: 
Friday, November 11, 2022

SOUTH HACKENSACK, N.J., Nov. 11, 2022 /PRNewswire-PRWeb/ -- Bio-LCB™ - Light Cured Base and Liner Bio-LCB was developed as a shock-absorbing protective base/liner under composites, amalgams, and other cement materials. Unlike other bases/liners, Bio-LCB provides superior strength, bonds to dentin, and promotes dentin remineralization. The proprietary UDMA-based formulation forms calcium hydroxide upon curing which results in an increase in pH. This action protects the pulp, stimulating pulpal cells to form dentin and decreases the risk of secondary decay. This unique composition also contains remineralizing agents which are released upon setting to form hydroxyapatite and further aid in the remineralization of the surrounding dentition.

Key Points: 
  • Bio-LCB was developed as a shock-absorbing protective base/liner under composites, amalgams, and other cement materials.
  • Unlike other bases/liners, Bio-LCB provides superior strength, bonds to dentin, and promotes dentin remineralization.
  • Pricing and Availability Bio-LCB Light Cured Base and Liner is available now as a Starter Pack with two syringes (2g ea.)
  • and 8 tips for a suggested retail price of $37.50 or as an Economy Pack with four syringes (2g ea.)